Invention Publication
- Patent Title: RE-FOLDED HUMAN SERUM ALBUMIN AND USE THEREOF FOR ANTI-TUMOR
-
Application No.: US18025637Application Date: 2021-09-10
-
Publication No.: US20230348566A1Publication Date: 2023-11-02
- Inventor: Chi-Ming LIANG , Jeng-Jer SHIEH , Chung-Hsuan CHEN , Shu-Mei LIANG
- Applicant: Academia Sinica
- Applicant Address: TW Taipei
- Assignee: Academia Sinica
- Current Assignee: Academia Sinica
- Current Assignee Address: TW Taipei
- International Application: PCT/US2021/049816 2021.09.10
- Date entered country: 2023-03-09
- Main IPC: C07K14/765
- IPC: C07K14/765 ; A61P35/00

Abstract:
Re-folded human serum albumin (rfHSA) and use thereof for anti-tumor are disclosed. The rfHSA comprises the primary amino acid sequence of naive human serum albumin, in which the rfHSA in a solution is oval shape, not fibrillar, and the naive HSA is globular. The rfHSA is used for treating cancer or a tumor in a subject in need thereof The rfHSA may also be used as a reagent for detecting the presence of a cancer cell associated with integrin β1 or serine/threonine protein kinase Akt and extracellular signal-regulated kinase 1/2 (ERK1/2) in a tumor sample or as a reagent for inhibiting phosphorylation of Akt and ERK 1/2 in a cancer cell sample. A cell lysate of a cancer cell treated with rfHSA, a vaccine composition comprising the cancer cell lysate, and use thereof are also disclosed. Also disclosed is a method tor preparing rfHSA.
Information query